Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Francesco Schettini"'
Autor:
Natàlia Lorman-Carbó, Olga Martínez-Sáez, Aranzazu Fernandez-Martinez, Patricia Galván, Nuria Chic, Isabel Garcia-Fructuoso, Adela Rodríguez, Raquel Gómez-Bravo, Francesco Schettini, Paula Blasco, Oleguer Castillo, Blanca González-Farré, Barbara Adamo, Maria Vidal, Montserrat Muñoz, Charles M. Perou, Marcos Malumbres, Joaquín Gavilá, Tomás Pascual, Aleix Prat, Fara Brasó-Maristany
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract This study examines the biological effects of palbociclib and ribociclib in hormone receptor-positive breast cancer, pivotal to the HARMONIA prospective phase III clinical trial. We explore the downstream impacts of these CDK4/6 inhibitors,
Externí odkaz:
https://doaj.org/article/ea86ec3e16194f1f8bdd3ad02a335dd9
Autor:
Anna Crispo, Livia S. A. Augustin, Assunta Luongo, Claudia Calderaio, Joao Breda, Sergio Coluccia, Alessandra Calabrese, Vittorio Marrazzo, Rosa Giannatiempo, Paola Trasacco, Elvira Palumbo, Sara Vitale, Giuseppe Porciello, Piergiacomo Di Gennaro, Roberta Caputo, Giuseppe Buono, Claudio Vernieri, Francesco Schettini, Maria Grimaldi, Flavia Nocerino, Egidio Celentano, Alfonso Amore, Mario Giuliano, Pietro De Placido, Carmine De Angelis, Roberto Bianco, Michelino De Laurentiis, Carlo La Vecchia, Grazia Arpino
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Obesity and metabolic disorders have been associated with poor outcomes in non-Mediterranean breast cancer (BC) patients. The purpose of this study was to investigate the prognostic potential of anthropometric variables in patients with earl
Externí odkaz:
https://doaj.org/article/f3a2ca9b48954ebe9d773daeec362742
Autor:
Francesco Schettini, Silvana Saracchini, Anna Bassini, Wally Marus, Serena Corsetti, Ilaria Specogna, Manuela Bertola, Elvia Micheli, Ralph M. Wirtz, Mark Laible, Uğur Şahin, Carla Strina, Manuela Milani, Sergio Aguggini, Richard Tancredi, Elena Fiorio, Sandro Sulfaro, Daniele Generali
Publikováno v:
Breast, Vol 76, Iss , Pp 103753- (2024)
Background: Neoadjuvant chemotherapy (NACT) is widely used in the treatment of triple-negative and HER2-positive breast cancer (BC), but its use in estrogen receptor (ER) and/or progesterone receptor (PR) positive/HER2-negative BC is questioned becau
Externí odkaz:
https://doaj.org/article/685e98291b35410783bf6f6dcacb65bd
Autor:
Benedetta Conte, Fara Brasó-Maristany, Adela Rodríguez Hernández, Tomás Pascual, Guillermo Villacampa, Francesco Schettini, Maria J. Vidal Losada, Elia Seguí, Laura Angelats, Isabel Garcia-Fructuoso, Raquel Gómez-Bravo, Natàlia Lorman-Carbó, Laia Paré, Mercedes Marín-Aguilera, Olga Martínez-Sáez, Barbara Adamo, Esther Sanfeliu, Beatrice Fratini, Claudette Falato, Núria Chic, Ana Vivancos, Patricia Villagrasa, Johan Staaf, Joel S. Parker, Charles M. Perou, Aleix Prat
Publikováno v:
EBioMedicine, Vol 102, Iss , Pp 105043- (2024)
Summary: Background: Early-stage triple-negative breast cancer (TNBC) displays clinical and biological diversity. From a biological standpoint, immune infiltration plays a crucial role in TNBC prognosis. Currently, there is a lack of genomic tools ai
Externí odkaz:
https://doaj.org/article/e280cec22ed2498189d321ebd159a946
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e23367- (2024)
In the last couple of decades substantial therapeutic improvements deeply influenced the treatment of HER2-positive metastatic breast cancer. The most impactful advancements were obtained especially in the first-line setting, with the trastuzumab/per
Externí odkaz:
https://doaj.org/article/85912a339b0a4254bffe9d44c44830ba
Autor:
Massimo Di Maio, Claudia Bighin, Francesco Schettini, Tommaso Ruelle, Laura Marandino, Alessandra Fabi, Carmine De Angelis, Mario Giuliano, Pietro De Placido, Michelino De Laurentiis, Ferdinando Riccardi, Caterina Picotto, Fabio Puglisi, Lucia Del Mastro, Grazia Arpino
Publikováno v:
Breast, Vol 72, Iss , Pp 103583- (2023)
Background: Treatment for HER2-positive (+) metastatic breast cancer has improved in the last decade. We analyzed treatment changes over time and their impact on patients outcomes in a real-world dataset. Methods: Data from 637 HER2+ patients with me
Externí odkaz:
https://doaj.org/article/4d2b4ec77a90481d9884d1101fc4625e
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/ae5d8a44a8a848f6b108ffcae617c8d9
Autor:
Francesco Schettini, Maria Valeria De Bonis, Carla Strina, Manuela Milani, Nicoletta Ziglioli, Sergio Aguggini, Ignazio Ciliberto, Carlo Azzini, Giuseppina Barbieri, Valeria Cervoni, Maria Rosa Cappelletti, Giuseppina Ferrero, Marco Ungari, Mariavittoria Locci, Ida Paris, Giovanni Scambia, Gianpaolo Ruocco, Daniele Generali
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Mathematical models based on partial differential equations (PDEs) can be exploited to handle clinical data with space/time dimensions, e.g. tumor growth challenged by neoadjuvant therapy. A model based on simplified assessment of tumor mali
Externí odkaz:
https://doaj.org/article/8ab5d27f2a0c432f915f67cda4c6e7d3
Autor:
Andrea Rocca, Fabiola Giudici, Carmine Antonio Donofrio, Cristina Bottin, Maurizio Pinamonti, Benvenuto Ferrari, Francesco Schettini, Estela Pineda, Stefano Panni, Marika Cominetti, Patrizia D’Auria, Simonetta Bianchini, Elena Varotti, Marco Ungari, Stefano Ciccarelli, Marzia Filippini, Sarah Brenna, Valentina Fiori, Tomas Di Mambro, Angelo Sparti, Mauro Magnani, Fabrizio Zanconati, Daniele Generali, Antonio Fioravanti
Publikováno v:
Cells, Vol 13, Iss 7, p 597 (2024)
Glioblastoma is the most frequent and aggressive brain tumor in adults. This study aims to evaluate the expression and prognostic impact of CD99, a membrane glycoprotein involved in cellular migration and invasion. In a cohort of patients with gliobl
Externí odkaz:
https://doaj.org/article/72f2663c2c414c968a37c62da85a97d3
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/fc3a7992752645b0a4219b489965a012